SCHEMBL11295609

SCHEMBL11295609

NCCC(=O)C=Cc1ccccc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.72
HAO1 Q9UJM8 1/20 0.61
MAPT P10636 6/20 0.57
LMNA P02545 3/20 0.57
HDAC3 O15379 2/20 0.57
HDAC4 P56524 2/20 0.57
HDAC1 Q13547 2/20 0.57
HDAC2 Q92769 2/20 0.57
HDAC8 Q9BY41 2/20 0.57
HDAC6 Q9UBN7 2/20 0.57
PLIN1 O60240 2/20 0.57
RECQL P46063 2/20 0.57
PLIN5 Q00G26 2/20 0.57
ABHD5 Q8WTS1 2/20 0.57
TNKS O95271 1/20 0.57
HCAR2 Q8TDS4 1/20 0.57
HDAC7 Q8WUI4 1/20 0.57
HDAC10 Q969S8 1/20 0.57
HDAC11 Q96DB2 1/20 0.57
TNKS2 Q9H2K2 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11308676 1.00 ALDH1A1 (0.72) ALDH1A1HAO1MAPTLMNAHDAC3
SCHEMBL13039630 0.90 ALDH1A1 (0.88) ALDH1A1HAO1MAPTLMNAHDAC3
SCHEMBL1285622 0.84 ALDH1A1 (1.00) ALDH1A1HAO1MAPTLMNAHDAC3
SCHEMBL27727862 0.84 ALDH1A1 (0.72) ALDH1A1HAO1MAPTLMNAHDAC3
SCHEMBL27525601 0.84 ALDH1A1 (0.72) ALDH1A1HAO1MAPTLMNAHDAC3
SCHEMBL1285623 0.84 ALDH1A1 (1.00) ALDH1A1HAO1MAPTLMNAHDAC3
SCHEMBL3439644 0.83 HAO1 (0.84) ALDH1A1HAO1MAPTLMNAHDAC3
SCHEMBL316674 0.83 HAO1 (0.84) ALDH1A1HAO1MAPTLMNAHDAC3
SCHEMBL6748868 0.82 ALDH1A1 (0.70) ALDH1A1HAO1MAPTLMNAHDAC3
SCHEMBL574953 0.82 ALDH1A1 (0.70) ALDH1A1HAO1MAPTLMNAHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0043141-A1 Pharmaceutical compositions having antiviral activity for topical administration and the use of 1-(substituted phenyl)-5-(4-morpholinyl)-1-penten-3-one compounds for the preparation of pharmaceutical compositions having an antiviral effect MERRELL DOW PHARMACEUTICALS INC. (US) 1982-01-06 EP disclosed
EP-0043141-A1 Pharmaceutical compositions having antiviral activity for topical administration and the use of 1-(substituted phenyl)-5-(4-morpholinyl)-1-penten-3-one compounds for the preparation of pharmaceutical compositions having an antiviral effect MERRELL DOW PHARMACEUTICALS INC. (US) 1982-01-06 EP disclosed
US-4288456-A Compositions containing 1-aryl-5-(2-propenylamino)-1-penten-3-ones and method for treating inflammatory conditions E. R. SQUIBB & SONS, INC. (US) 1981-09-08 US disclosed
US-4173649-A ANTIULCER AGENTS E. R. SQUIBB & SONS, INC. (US) 1979-11-06 US disclosed